Boston Scientific Corporation (BSX) Options Heat Up

Boston Scientific Corporation (BSX) traders are picking up May-dated options

Mar 17, 2015 at 1:25 PM
facebook twitter linkedin


Boston Scientific Corporation (NYSE:BSX) is just off an eight-year peak of $17.81, with the stock last seen 0.8% higher at $17.38. The medical device maker is extending yesterday's FDA-inspired surge, and option traders are placing bets on the equity's trajectory over the next couple of months.

BSX's short-term options are popular, as the equity's 30-day at-the-money implied volatility has jumped 5% to 24.8%. While calls are outnumbering puts -- and trading at nearly twice the average intraday clip -- BSX put volume is running at six times the norm.

Both bears and bulls are eyeing the May series, with potential buy-to-open activity detected at the May 15 put and May 17 call -- the two most active contracts thus far. Buyers of the put are either gambling on BSX to backpedal south of $15 -- in territory not charted since the stock's mid-February bull gap -- or are looking to hedge their long stock positions. The call buyers, meanwhile, are expecting BSX to extend its quest for new highs north of $17 before options expire on Friday, May 15.

Expanding our sentiment scope, while most analysts are already in the bulls' corner -- 14 of 22 offer up "buy" or better opinions -- price-target hikes aren't outside the realm of possibility. The average 12-month price target on Boston Scientific Corporation (NYSE:BSX) sits at $17.95 -- just a stone's throw from today's new high.

Daily Chart of BSX since December 2014
 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Master Portfolio Trial
 


 


 
Special Offers from Schaeffer's Trading Partners